BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35953459)

  • 1. miR-15b-5p REGULATES THE NLRP3 INFLAMMASOME SIGNAL THROUGH TARGETING SIRT3 TO REGULATE HYPOXIA/REOXYGENATION-INDUCED CARDIOMYOCYTE PYROPTOSIS PROCESS.
    Xu J; Chen X; Nie W
    Shock; 2022 Aug; 58(2):147-157. PubMed ID: 35953459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of lncRNA HULC Attenuates Myocardial Ischemia/reperfusion Injury in Rat Models and Apoptosis of Hypoxia/reoxygenation Cardiomyocytes via Targeting miR-377-5p through NLRP3/Caspase‑1/IL‑1β Signaling Pathway Inhibition.
    Liang H; Li F; Li H; Wang R; Du M
    Immunol Invest; 2021 Nov; 50(8):925-938. PubMed ID: 32674625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-129-5p Protects H9c2 Cardiac Myoblasts From Hypoxia/Reoxygenation Injury by Targeting TRPM7 and Inhibiting NLRP3 Inflammasome Activation.
    Liu S; Liao Q; Xu W; Zhang Z; Yin M; Cao X
    J Cardiovasc Pharmacol; 2021 May; 77(5):586-593. PubMed ID: 33951695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
    Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
    J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-155-5p accelerates cerebral ischemia-reperfusion inflammation injury and cell pyroptosis via DUSP14/ TXNIP/NLRP3 pathway.
    Shi Y; Li Z; Li K; Xu K
    Acta Biochim Pol; 2022 Nov; 69(4):787-793. PubMed ID: 36441582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of miR-126 in hypoxia-reoxygenation-induced cardiomyocyte pyroptosis by regulating HMGB1 and NLRP3 inflammasome.
    Fei L; Zhang N; Zhang J
    Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):500-509. PubMed ID: 35297734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA Rian reduces cardiomyocyte pyroptosis and alleviates myocardial ischemia-reperfusion injury by regulating by the miR-17-5p/CCND1 axis.
    Kang H; Yu H; Zeng L; Ma H; Cao G
    Hypertens Res; 2022 Jun; 45(6):976-989. PubMed ID: 35264782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart.
    Bian Y; Pang P; Li X; Yu S; Wang X; Liu K; Ju J; Wu H; Gao Y; Liu Q; Jia Y; Qu Z; Bi X; Mei Z; Yin X; Wang N; Du W; Yang B
    J Mol Cell Cardiol; 2021 Sep; 158():128-139. PubMed ID: 34043986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-703 protects against hypoxia/reoxygenation-induced cardiomyocyte injury via inhibiting the NLRP3/caspase-1-mediated pyroptosis.
    Wei X; Peng H; Deng M; Feng Z; Peng C; Yang D
    J Bioenerg Biomembr; 2020 Jun; 52(3):155-164. PubMed ID: 32291604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-302a-3p targets FMR1 to regulate pyroptosis of renal tubular epithelial cells induced by hypoxia-reoxygenation injury.
    Bai T; Cui Y; Yang X; Cui X; Yan C; Tang Y; Cao X; Dong C
    Exp Physiol; 2021 Dec; 106(12):2531-2541. PubMed ID: 34605097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP7-SOX9-miR-96-5p-NLRP3 Network Regulates Myocardial Injury and Cardiomyocyte Pyroptosis in Sepsis.
    Gong X; Li Y; He Y; Zhou F
    Hum Gene Ther; 2022 Oct; 33(19-20):1073-1090. PubMed ID: 35686454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-139 protects against oxygen-glucose deprivation/reoxygenation (OGD/R)-induced nerve injury through targeting c-Jun to inhibit NLRP3 inflammasome activation.
    Wang QS; Luo XY; Fu H; Luo Q; Wang MQ; Zou DY
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105037. PubMed ID: 32807449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of total glucosides of paeony in hypoxia/reoxygenation-induced cardiomyocyte pyroptosis.
    Yan X; Huang Y
    J Bioenerg Biomembr; 2021 Dec; 53(6):643-653. PubMed ID: 34585325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of lncRNA TUG1 Alleviates NLRP3 Inflammasome-Mediated Cardiomyocyte Pyroptosis Through Targeting the miR-186-5p/XIAP Axis in Coronary Microembolization-Induced Myocardial Damage.
    Zhou Y; Li T; Chen Z; Huang J; Qin Z; Li L
    Front Immunol; 2021; 12():637598. PubMed ID: 34163467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular mechanism of MiR-26a-5p regulates autophagy and activates NLRP3 inflammasome to mediate cardiomyocyte hypertrophy.
    Tang LQ; Wang W; Tang QF; Wang LL
    BMC Cardiovasc Disord; 2024 Jan; 24(1):18. PubMed ID: 38172711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-144-5p/CCL12 Signaling Axis Modulates Ischemic Preconditioning-Mediated Cardio-protection by Reducing Cell Viability, Enhancing Cell Apoptosis, Fibrosis, and Pyroptosis.
    Chen JY; Ruan HJ; Chen SY; Wang XQ; Wen JM; Wang ZX
    Appl Biochem Biotechnol; 2023 Mar; 195(3):1999-2014. PubMed ID: 36401720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of microRNA-297 alleviates THLE-2 cell injury induced by hypoxia/reoxygenation by inhibiting NLRP3 inflammasome activation via sirtuin 3.
    Yue Y; Du Z; Tao J; Shi L
    Can J Physiol Pharmacol; 2022 Feb; 100(2):125-133. PubMed ID: 34559973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of METTL3-Mediated m
    Wang X; Li Y; Li J; Li S; Wang F
    Cardiovasc Drugs Ther; 2023 Jun; 37(3):435-448. PubMed ID: 35066738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway.
    Dai Y; Wang S; Chang S; Ren D; Shali S; Li C; Yang H; Huang Z; Ge J
    J Mol Cell Cardiol; 2020 May; 142():65-79. PubMed ID: 32087217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid aggravates myocardial ischemia-reperfusion injury via ROS/NLRP3 pyroptosis pathway.
    Shen S; He F; Cheng C; Xu B; Sheng J
    Biomed Pharmacother; 2021 Jan; 133():110990. PubMed ID: 33232925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.